Loading stock…

Novanta Inc. (NOVT) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Novanta Inc.

NOVTMarket cap $5.43BPrice $143.6

Country🇺🇸United States

SectorTechnology

IndustryElectronic Equipment

Makes precision photonics, sensors, and medical components that power surgical robots, lasers, and manufacturing systems worldwide. Its tech hides inside thousands of other companies' products, making Novanta a critical but invisible link in medical and industrial innovation.

In Bastion Portfolios?

52W Return+36%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+4%5

Revenue Forecast

Rev CAGR (1y)+16%7

Rev CAGR (3y)+15%8

Rev CAGR (5y)+11%8

Earnings Forecast

EPS Growth Y+1+180%10

EPS Growth Y+2+20%8

EPS Growth Y+3+25%8

Quality

Margins

EBIT Margin12%5

Net Income Margin6%4

Free Cash Flow Margin11%6

Debt

Net Debt/EBITDA-2.210

Efficiency

ROE5%3

ROA3%5

Earnings Stability55

GEAR+AVERAGE36

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)332

P/E Ratio (Forward 3y)232

P/BV3.44

EV Multiples

EV/EBITDA Fwd193

EV/EBIT Fwd243

Yield

Free Cash Flow Yield2.1%4

Dividend Yieldna–

Momentum

Short term

1 month return-4%6

3 month return-3%5

YTD return+21%8

Mid term

Price vs 52wHigh81%6

1 year return+40%9

Long term

3 year return-0%3

5 year return-11%3

Risk Shield

Price Risk

Beta1.81

Volatility52%3

Free Cash Flow

Free Cash Flow Margin11%6

Free Cash Flow Yield2.1%4

Quality

ROCE7%4

Earnings Stability55

Net Debt/EBITDA-2.210

02Growth

Is it actually growing, and how fast?

NOVTNovanta

Revenue FY25$981M

GROWTH RATING↗

STRONG76 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+4%5

Revenue, next 1Y+16%7

Revenue, next 3Y, CAGR+15%8

Revenue, next 5Y, CAGR+11%8

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+180%10

EPS growth, FY27E+20%8

EPS growth, FY28E+25%8

GROWTH ASSESSMENT

STRENGTHS

It out-grows 76% of companies worldwide.

Revenue is set to grow 15%/yr over the next 3 years, ahead of most of the market.8/10

Revenue grew 4%/yr over the last 3 years and is set to grow 15%/yr from here.

The runway holds up: revenue is set to grow 11%/yr over five years.8/10

Earnings are set to grow faster than sales (EPS about 25%/yr vs revenue 15%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE45 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-4%6

3-month return-3%5

YTD return+21%8

MID & LONG-TERM▾SCORE

% of 52-week high81%6

1-year return+40%9

3-year return-0%3

5-year return-11%3

MOMENTUM ASSESSMENT

STRENGTHS

It's up 40% over the past year, but 19% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming so far this year (+21%).

WATCH

Returns sit at the market level over the past month (-4%) and over three months (-3%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-0.3% over three years and -11% over five), behind 70% of the market.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Novanta Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

NOVTNovanta

Revenue FY25$981M

GROWTH RATING↗

STRONG76 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+4%5

Revenue, next 1Y+16%7

Revenue, next 3Y, CAGR+15%8

Revenue, next 5Y, CAGR+11%8

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+180%10

EPS growth, FY27E+20%8

EPS growth, FY28E+25%8

GROWTH ASSESSMENT

STRENGTHS

It out-grows 76% of companies worldwide.

Revenue is set to grow 15%/yr over the next 3 years, ahead of most of the market.8/10

Revenue grew 4%/yr over the last 3 years and is set to grow 15%/yr from here.

The runway holds up: revenue is set to grow 11%/yr over five years.8/10

Earnings are set to grow faster than sales (EPS about 25%/yr vs revenue 15%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE45 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-4%6

3-month return-3%5

YTD return+21%8

MID & LONG-TERM▾SCORE

% of 52-week high81%6

1-year return+40%9

3-year return-0%3

5-year return-11%3

MOMENTUM ASSESSMENT

STRENGTHS

It's up 40% over the past year, but 19% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming so far this year (+21%).

WATCH

Returns sit at the market level over the past month (-4%) and over three months (-3%).

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-0.3% over three years and -11% over five), behind 70% of the market.

BOTTOM LINE

Mixed Momentum

Horizons disagree or sit near the middle of the pack. Momentum investors may want a clearer trend before sizing up. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Novanta Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community